Treanda (Bendamustine) is used for the treatment of chronic lymphocytic leukemia. It is also used to treat indolent B-cell non-Hodgkin lymphoma after the unsuccessful treatment of this condition with other medications. Bendamustine belongs to a class of drugs called alkylating agents; it interferes with the growth and spread in the body.
The brand name Treanda is from Canada and is manufactured by Lundbeck. This medication is available in the powder vial for injection. It comes in strengths of 25mg and 100mg.
Common side effects include:
• Black, tarry stools or blood in the urine or stool;
• Chest pain;
• Chills, cough, diarrhea, fever, muscle aches and headache;
• Lack or loss of strength;
• Swelling of the feet or lower legs;
• Unusual bleeding or bruising;
• Vomiting, etc.
You should not receive Treanda if you are allergic to bendamustine or mannitol (Osmitrol). Before you start treatment with Treanda, tell your doctor if you have a weak immune system, fever or other signs of infection, a metabolic disorder or electrolyte imbalance, liver or kidney disease, or if you smoke. Do not receive this medication if you are pregnant or planning to become pregnant. It is unknown whether bendamustine passes into breast milk or if it could harm a nursing baby. Inform your doctor if you are breast-feeding a baby.